Silicone Foam Implant Coatings for Capsular Contracture
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Soft tissue implants often suffer from capsular contracture due to inflammatory responses, which can lead to discomfort and reduced efficacy, especially with smooth surface implants, and existing textured coatings like polyurethane are biodegradable and may produce carcinogenic byproducts.
Innovation Solution
Development of open celled foams with a matrix of interconnected silicone spheres that provide a textured coating for implants, allowing for tissue ingrowth and preventing capsular contracture, using a process involving solvent-based emulsions and curing to create a structure with a theoretical void space of 50% to 99%, which promotes tissue integration without the need for biodegradable materials.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If polyurethane textured coatings are used to reduce capsular contracture, then capsular formation is reduced, but the coatings are biodegradable and may produce carcinogenic byproducts
Solution Approach 1:
The patent changes the material composition parameter from biodegradable polyurethane to non-biodegradable silicone foam, maintaining the textured surface structure while eliminating the harmful degradation byproducts. The silicone foam provides sustained mechanical texture without chemical degradation.
Solution Approach 2:
The patent uses composite silicone foam material that combines the beneficial mechanical properties of foam structures with the biocompatibility and non-biodegradability of silicone, creating a material that prevents capsular contracture without producing harmful byproducts.
2Reliability
If polyurethane textured coatings are used to reduce capsular contracture, then capsular formation is reduced, but the manufacturing process becomes increasingly complicated and costly
Solution Approach 1:
The patent segments the manufacturing process into distinct stages: forming the silicone foam core structure, applying the textured surface pattern, and curing. This segmentation simplifies the overall manufacturing complexity by breaking down the complex coating process into manageable steps.
Solution Approach 2:
The patent employs porous silicone foam as the base material, which inherently provides a textured surface structure. This eliminates the need for complex post-coating processes to create texture, as the porous structure is built-in during foam formation, simplifying manufacturing.
3Ease of manufacture
If smooth surface implants are used, then manufacturing is simpler, but capsular formation and contracture occur more frequently
Solution Approach 1:
The patent uses porous silicone foam that provides an inherent textured surface structure during manufacturing, eliminating the need for complex texturing processes while effectively preventing capsular contracture through the mechanical disruption of collagen fiber alignment.
Solution Approach 2:
The patent changes the surface parameter from smooth to textured through the foam structure, and changes the material parameter to non-biodegradable silicone, achieving both manufacturing simplicity and effective capsular contracture prevention.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The open celled foam coatings effectively prevent capsular contracture by promoting tissue integration and disorganization of collagen fibers, reducing the risk of implant-related pain and improving the longevity of implant efficacy without the drawbacks of biodegradable materials.
Implementation Method 1
curing the emulsion thereby forming the open celled foam
Data Source
AI summary
Described herein are methods of making open celled foams including a matrix of interconnected spheres. The open celled foams are silicone based materials and can be used to coat implants, such as breast implants, and function to encourage tissue ingrowth and reduce capsular formation.